((E)-N?(3,5-di-tert-butil-2-hedroxybenzilidene)-2-hydroxybenzohydrazide (H3sahz)2 Copper (II) Complex: Synthesis, Crystal Structures, in silico Evaluations, and Enzymatic Inhibition

dc.contributor.authorFatullayeva, Perizad Amrulla
dc.contributor.authorMejidov, Ajdar Akper
dc.contributor.authorSafronenko, Marina Gennadievna
dc.contributor.authorNikolayevich Khrustalev, Victor
dc.contributor.authorYalcin, Bahaddin
dc.contributor.authorSadeghian, Nastaran
dc.contributor.authorSadeghi, Morteza
dc.contributor.authorSadeghian, Nastaran
dc.date.accessioned2025-10-18T09:58:45Z
dc.date.created2023
dc.date.issued2023
dc.departmentFakülteler, Fen Fakültesi, Biyoteknoloji Bölümü
dc.description.abstractIn this study, (E)-N'(3,5-di-tert-butil-2-hedroxybenzilidene)-2-hydroxybenzohydrazide (H3sahz) 2 and its copper (II) complex has been synthesized and evaluated by methods FTIR, UV-Vis, EPR, and single crystal X-ray analysis. It has been shown, that H3sahz crystallizes as a dimer through hydrogen bonds. H3sahz with copper nitrate forms [Cu(H(2)sahz)(NO3)(H2O)] complex, which according to X-ray diffraction analysis has a distorted square pyramidal structure. The complex was screened for alpha-glucosidase (alpha-Glu), acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) inhibitory abilities. Results displayed that IC50 and K-i values of the novel complex for AChE, BChE, and aGlu enzymes were obtained at 0.93-2.14, 1.01-2.03, and 73.86-102.65 mu M, respectively. The molecular docking outcomes have shown that the synthetic complex has a lower affinity for aglucosidase compared to acarbose. But the inhibition ability of H(3)sahz for acetylcholinesterase and butyrylcholinesterase enzymes was greater than that of tacrine. These findings indicate that the (H(3)sahz)(2) complex may be considered a possible candidate for the development and discovery of compounds effective in inhibiting the relevant enzymes.
dc.description.sponsorshipMinistry of Science and Higher Education of the Russian Federation [075-03-2020-223 (FSSF-2020-0017)]; RUDN University Strategic Academic Leadership Program
dc.description.sponsorshipThis work was funded by the Ministry of Science and Higher Education of the Russian Federation (award no. 075-03-2020-223 (FSSF-2020-0017)). The publication has been prepared with the support of the RUDN University Strategic Academic Leadership Program.
dc.identifier.doi10.1002/slct.202300319
dc.identifier.issn2365-6549
dc.identifier.issue15
dc.identifier.orcidfatullayeva, perizad/0000-0002-2702-7321
dc.identifier.orcidSadeghian, nastaran/0009-0004-2966-9231
dc.identifier.orcidTaslimi, Parham/0000-0002-3171-0633
dc.identifier.orcidSadeghi, Morteza/0000-0002-5027-4777;
dc.identifier.scopus2-s2.0-85153327639
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1002/slct.202300319
dc.identifier.urihttps://hdl.handle.net/11772/19824
dc.identifier.volume8
dc.identifier.wosWOS:000973624300001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherWiley-V C H Verlag Gmbh
dc.relation.ispartofChemistryselect
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzWoS_20251016
dc.subjectBioactivity
dc.subjectEnzymes Inhibition
dc.subjectMolecular Docking
dc.subjectSalicylic Acid Hydrazide
dc.subjectX-Ray
dc.title((E)-N?(3,5-di-tert-butil-2-hedroxybenzilidene)-2-hydroxybenzohydrazide (H3sahz)2 Copper (II) Complex: Synthesis, Crystal Structures, in silico Evaluations, and Enzymatic Inhibition
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication7f83844e-1b57-4c97-b59d-6bd6facb1def
relation.isAuthorOfPublication.latestForDiscovery7f83844e-1b57-4c97-b59d-6bd6facb1def

Dosyalar